AFS
SRNE

Annapolis Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Annapolis Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$1K – 463
2020
Q4 		$1K Buy
+100
New +$803 ﹤0.01% 400

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Annapolis Financial Services's SRNE Position: Q1 2021 in Review

Annapolis Financial Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2021, closing a stake of 100 shares — an estimated $1K sold.

Annapolis Financial Services first reported a position in SRNE in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 231 funds tracked by Wall St. Rank hold SRNE as of Q1 2021.

  • Annapolis Financial Services reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Annapolis Financial Services sold 100 Sorrento Therapeutics, Inc. shares in Q1 2021, an estimated $1K.
  • Annapolis Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 1 quarter.
  • Annapolis Financial Services's Sorrento Therapeutics, Inc. position peaked at $1K in Q4 2020.
  • 231 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2021.

Based on Annapolis Financial Services's 13F filing for Q1 2021, filed 6 May 2021.